can semaglutide cause death Weight loss drugs halve heart patients' risk of early death, study finds | Health Saving kidneys, hearts and lives':

Gaudelli, N.M

GLP-1RA can induce glucose-dependent stimulation of insulin secretion, reduce glucagon release, reduce hepatic glucose output, delay gastric emptying and increase satiety, resulting in moderate reductions in glycated hemoglobin (HbA1c), body weight and systolic blood pressure, the risk of hypoglycemia is lower

PubMed Wang, Y., Feng, Z., & Yu, L

Kidney Int Suppl (2011) 2022;12:711 [DOI] [PMC free article] [PubMed] [Google Scholar] 4

Now, robust clinical trial data are catching up to these observations

The documentation must name the specific peptide compound, dosage, prescribing physician or principal investigator, and patient or researcher name